Get an overview of the application of pharmacokinetic concepts to all stages of drug development. The focus will be on the practical application of pharmacokinetic principles in the design and conducting and interpreting preclinical and clinical pharmacokinetic studies. Areas to be covered will include pharmacokinetic concepts (absorption, distribution, metabolism, and elimination), pharmacodynamics, regulatory requirements, and guidance for in vitro and in vivo studies, and practical examples of preclinical and clinical pharmacokinetic and pharmacodynamic analyses. This entry-level course will be appropriate for individuals with a background in biological sciences who contribute to the design, conduct, analysis or interpretation of pharmacokinetic studies or who have an interest in the role of pharmacokinetics in drug development.
Course Number: BIOL-40176
Credit: 3.00 unit(s)
Related Certificate Programs: ADMET Process
+ Expand All
-
1/10/2022 - 3/14/2022
$675
Online
-
-
-
CLASS TYPE:
Online Asynchronous.
This course is entirely web-based and to be completed asynchronously between the published course start and end dates. Synchronous attendance is NOT required.
You will have access to your online course on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.
Bozigian, Haig, Chief Development Officer, Neurocrine Biosciences
Haig Bozigian is the chief development officer at Neurocrine Biosciences. Prior to joining Neurocrine, he was director of pharmaceutical development for ProCyte Corporation from 1993-1997, associate director of pharmacokinetics and metabolism at Sphinx Pharmaceuticals Corporation from 1990-1993 and clinical pharmacokineticist at Glaxo Inc from 1988-1990. He holds a Ph.D. in pharmaceutical sciences from the University of Arizona and a master's in pharmacodynamics and toxicology from the University of Nebraska Medical Center.
Bozigian, Haig, Chief Development Officer, Neurocrine Biosciences
Haig Bozigian is the chief development officer at Neurocrine Biosciences. Prior to joining Neurocrine, he was director of pharmaceutical development for ProCyte Corporation from 1993-1997, associate director of pharmacokinetics and metabolism at Sphinx Pharmaceuticals Corporation from 1990-1993 and clinical pharmacokineticist at Glaxo Inc from 1988-1990. He holds a Ph.D. in pharmaceutical sciences from the University of Arizona and a master's in pharmacodynamics and toxicology from the University of Nebraska Medical Center.
-
TEXTBOOKS:
REQUIREDNo textbook required.
No textbook required.
-
POLICIES:
No refunds after: 1/18/2022.
-
1/10/2022 - 3/14/2022
extensioncanvas.ucsd.edu
You will have access to your course materials on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.
There are no sections of this course currently scheduled. Please contact the Science & Technology department at 858-534-3229 or unex-sciencetech@ucsd.edu for information about when this course will be offered again.